Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 1058-1067

  Mothé, Bianca R ^a   Stewart, Barbara S ^a   Oseroff, Carla ^b   Bui, Huynh Hoa ^b   Stogiera, Stephanie ^a   Garcia, Zacarias ^b   Dow, Courtney ^a,b   Rodriguez Carreno, Maria Pilar ^c   Kotturi, Maya ^b   Pasquetto, Valerie ^b   Botten, Jason ^c   Crotty, Shane ^b   Janssen, Edith ^b   Buchmeier, Michael J ^c   Sette, Alessandro ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CELL TRANSFER; CHRONIC DISEASE; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL MOUSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; OPEN READING FRAME; PERSISTENT INFECTION; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS MENINGITIS; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR GENETICS; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA;

EID: 34548733757     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.1058     Document Type: Article

References (69)

1. + T-cell-deficient mice. J. Virol. 68: 4700-4704.
2. + T cells. J. Exp. Med. 184: 863-871.
3. + T-cell response in acute hepatitis C. Gastroenterology 117: 933-941.
4. Kalams, S. A., S. P. Buchbinder, E. S. Rosenberg, J. M. Billingsley, D. S. Colbert, N. G. Jones, A. K. Shea, A. K. Trocha, and B. D. Walker. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J. Virol. 73: 6715-6720.
5. Kaufmann, D. E., P. M. Bailey, J. Sidney, B. Wagner, P. J. Norris, M. N. Johnston, L. A. Cosimi, M. M. Addo, M. Lichterfeld, M. Altfeld, et al. 2004. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 78: 4463-4477.
6. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68: 8056-8063.
7. Wherry, E. J., and R. Ahmed. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78: 5535-5545.
8. Fuller, M. J., A. Khanolkar, A. E. Tebo, and A. J. Zajac. 2004. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 172: 4204-4214.
9. Bailey, J., J. N. Blankson, M. Wind-Rotolo, and R. F. Siliciano. 2004. Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs. Curr. Opin. Immunol. 16: 470-476.
10. Hamer, D. H. 2004. Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it. Curr. HIV Res. 2: 99-111.
11. + T cell immunity: HCV evolution, from chimpanzees to man. J. Exp. Med. 201: 1709-1714.
12. Simmonds, P. 2004. Genetic diversity and evolution of hepatitis C virus: 15 years on. J. Gen. Virol. 85: 3173-3188.
13. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
14. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203: 2223-2227.
15. Grakoui, A., E. John Wherry, H. L. Hanson, C. Walker, and R. Ahmed. 2006. Turning on the off switch: regulation of anti-viral T cell responses in the liver by the PD-1/PD-L1 pathway. J. Hepatol. 45: 468-472.
16. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
17. Fuller, M. J., and A. J. Zajac. 2003. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170: 477-486.
18. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362: 758-761.
19. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
20. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
21. Oldstone, M. B. A. 2006. Viral persistence: parameters, mechanisms and future predictions. Virology 344: 111-118.
22. Oldstone, M. B. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263: 83-117.
23. Thomsen, A. R., A. Nansen, S. O. Andreasen, D. Wodarz, and J. P. Christensen. 2000. Host factors influencing viral persistence. Philos. Trans. R. Soc. London B. 355: 1031-1041.
24. Southern, P. 1996. Arenaviridae: the viruses and their replication. In Fields Virology. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippencott-Raven, Philadelphia, pp. 1505-1519.
25. Lenz, O., J. ter Meulen, H. D. Klenk, N. G. Seidah, and W. Garten. 2001. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl. Acad. Sci. USA 98: 12701-12705.
26. von Herrath, M., and J. L. Whitton. 2000. Animal models using lymphocytic choriomeningitis virus. In Current Protocols in Immunology, Wiley, New York, pp. 19.10.1-19.10.19.
27. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, and M. B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160: 521-540.
28. Ahmed, R., C. S. Hahn, T. Somasundaram, L. Villarete, M. Matloubian, and J. H. Strauss. 1991. Molecular basis of organ-specific selection of viral variants during chronic infection. J. Virol. 65: 4242-4247.
29. Salvato, M., P. Borrow, E. Shimomaye, and M. B. Oldstone. 1991. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J. Virol. 65: 1863-1869.
30. -). Virology 164: 517-522.
31. Oldstone, M. B., M. Salvato, A. Tishon, and H. Lewicki. 1988. Virus-lymphocyte interactions, III: biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts. Virology 164: 507-516.
32. Matloubian, M., S. R. Kolhekar, T. Somasundaram, and R. Ahmed. 1993. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67: 7340-7349.
33. Matloubian, M., T. Somasundaram, S. R. Kolhekar, R. Selvakumar, and R. Ahmed. 1990. Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice. J. Exp. Med. 172: 1043-1048.
34. Kunz, S., N. Sevilla, D. B. McGavern, K. P. Campbell, and M. B. Oldstone. 2001. Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan. J. Cell Biol. 155: 301-310.
35. Smelt, S. C., P. Borrow, S. Kunz, W. Cao, A. Tishon, H. Lewicki, K. P. Campbell, and M. B. Oldstone. 2001. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor α-dystroglycan correlate with viral tropism and disease kinetics. J. Virol. 75: 448-457.
36. Sevilla, N., D. B. McGavern, C. Teng, S. Kunz, and M. B. Oldstone. 2004. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 113: 737-745.
37. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14: 207-232.
38. + T cells upon acute versus persistent viral infection. Immunity 9: 449-457.
39. Brooks, D. G., L. Teyton, M. B. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79: 10514-10527.
40. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187: 1383-1393.
41. Oxenius, A., M. F. Bachmann, P. G. Ashton-Rickardt, S. Tonegawa, R. M. Zinkernagel, and H. Hengartner. 1995. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 25: 3402-3411.
42. + T cell responses. J. Immunol. 175: 5624-5628.
43. Oxenius, A., M. F. Bachmann, R. M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28: 390-400.
44. Whitmire, J. K., K. Murali-Krishna, J. Altman, and R. Ahmed. 2000. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements. Philos. Trans. R. Soc. London B 355: 373-379.
45. + T cells during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 161: 3215-3218.
46. Sette, A., S. Buus, S. Colon, J. A. Smith, C. Miles, and H. M. Grey. 1987. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 328: 395-399.
47. Crotty, S., M. M. McCausland, R. D. Aubert, E. J. Wherry, and R. Ahmed. 2006. Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease. Blood 108: 3085-3093.
48. Tangri, S., B. R. Mothe, J. Eisenbraun, J. Sidney, S. Southwood, K. Briggs, J. Zinckgraf, P. Bilsel, M. Newman, R. Chesnut, et al. 2005. Rationally engineered therapeutic proteins with reduced immunogenicity. J. Immunol. 174: 3187-3196.
49. Sidney, J., S. Southwood, C. Oseroff, M. F. Del Guercio, A. Sette, and H. Grey. 1998. Measurement of MHC/peptide interactions by gel filtration. In Current Protocols in Immunology, Wiley, New York, pp. 1311-1319.
50. Pasquetto, V., H. H. Bui, R. Giannino, C. Banh, F. Mirza, J. Sidney, C. Oseroff, D. C. Tscharke, K. Irvine, J. R. Bennink, et al. 2005. HLA-A*0201, HLAA* 1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol. 175: 5504-5515.
51. Probst, H. C., K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T. Dumrese, E. Jones, and M. F. van den Broek. 2003. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171: 5415-5422.
52. Buchmeier, M. J. 2002. Arenaviruses: protein structure and function. Curr. Top. Microbiol. Immunol. 262: 159-173.
53. Perez, M., R. C. Craven, and J. C. de la Torre. 2003. The small RING finger protein Z drives Arenavirus budding: implications for antiviral strategies. Proc. Natl. Acad. Sci. USA 100: 12978-12983.
54. Salvato, M., E. Shimomaye, and M. B. Oldstone. 1989. The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase. Virology 169: 377-384.
55. Whitton, J. L., A. Tishon, H. Lewicki, J. Gebhard, T. Cook, M. Salvato, E. Joly, and M. B. Oldstone. 1989. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63: 4303-4310.
56. Schulz, M., P. Aichele, R. Schneider, T. H. Hansen, R. M. Zinkernagel, and H. Hengartner. 1991. Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide. Eur. J. Immunol. 21: 1181-1185.
57. Buchmeier, M. J., and A. J. Zajac. 1999. Lymphocytic choriomeningitis virus. In Persistent Viral Infections. R. Ahmed and I. Chen, eds. Wiley and Sons, pp. 575-605.
58. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94: 6874-6879.
59. + T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J. Virol. 74: 2186-2192.
60. Kunz, S., and J. C. de la Torre. 2005. Novel antiviral strategies to combat human Arenavirus infections. Curr. Mol. Med. 5: 735-751.
61. Rosenberg, E. S., L. LaRosa, T. Flynn, G. Robbins, and B. D. Walker. 1999. Characterization of HIV-1-specific T-helper cells in acute and chronic infection. Immunol. Lett. 66: 89-93.
62. Rosenberg, E. S., M. Altfeld, S. H. Poon, M. N. Phillips, B. M. Wilkes, R. L. Eldridge, G. K. Robbins, R. T. D'Aquila, P. J. Goulder, and B. D. Walker. 2000. Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
63. + T cells and Th1 dominance during lymphocytic choriomeningitis virus infection. J. Virol. 74: 4429-4432.
64. Fuller, M. J., and A. J. Zajac. 2003. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170: 477-486.
65. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472.
66. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. A. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309.
67. Berger, D. P., D. Homann, and M. B. A. Oldstone. 2000. Defining parameters for successful immunocytotherapy of persistent viral infection. Virology 266: 257-263.
68. + T lymphocytes. Nature 421: 852-856.
69. Shedlock, D. J., J. K. Whitmire, J. Tan, A. S. MacDonald, R. Ahmed, and H. Shen. 2003. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J. Immunol. 170: 2053-2063.